The effect of l-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia
- 1 June 1982
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 100 (6), 990-995
- https://doi.org/10.1016/s0022-3476(82)80536-2
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- A syndrome of thrombosis and hemorrhage complicating l-asparaginase therapy for childhood acute lymphoblastic leukemiaThe Journal of Pediatrics, 1982
- Intracranial hemorrhage and focal seizures secondary to use of l-asparaginase during induction therapy of acute lymphocytic leukemiaThe Journal of Pediatrics, 1980
- L-ASPARAGINASE, ANTITHROMBIN III, AND THROMBOSISThe Lancet, 1980
- ANTITHROMBIN III DEFICIENCY DURING ASPARAGINASE THERAPYThe Lancet, 1980
- ANTITHROMBIN III DEFICIENCY DURING ASPARAGINASE THERAPYThe Lancet, 1980
- Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuriaThe Journal of Pediatrics, 1980
- Reduced antithrombin III levels during L-asparaginase therapyMedical and Pediatric Oncology, 1980
- Acute Deficiency of Thyroxine-Binding Globulin during L-Asparaginase TherapyNew England Journal of Medicine, 1979
- Heparin, Antithrombin, and Abnormal ClottingAnnual Review of Medicine, 1978
- Studies on a family with an elevated plasmalevel of factor V (proaccelerin) and a tendency to thrombosisThe Journal of Pediatrics, 1966